Showing results (601-610 of 689) with videos related to
Sort By:
Pageof 69
European Heart Journal. Cardiovascular Pharmacotherapy|December 28, 2021
Ischaemic and bleeding risk in atrial fibrillation with and without peripheral artery disease and efficacy and safety of full- and half-dose edoxaban vs. warfarin: insights from ENGAGE AF-TIMI 48Marc P Bonaca, Elliott M Antman, Jonathan W Cunningham, et al.The New England Journal of Medicine|March 16, 2006
Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarctionElliott M Antman, David A Morrow, Carolyn H McCabe, et al.Circulation. Cardiovascular Quality and Outcomes|June 3, 2024
Application of the Win Ratio Method in the ENGAGE AF-TIMI 48 Trial Comparing Edoxaban With Warfarin in Patients With Atrial FibrillationBrian A Bergmark, Jeong-Gun Park, Rose A Hamershock, et al.American Heart Journal|June 23, 2007
Global outcomes of ST-elevation myocardial infarction: comparisons of the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) registry and trialBenjamin A Steinberg, Nazanin Moghbeli, Jacqueline Buros, et al.European Heart Journal|December 5, 2013
Left atrial structure and function in atrial fibrillation: ENGAGE AF-TIMI 48Deepak K Gupta, Amil M Shah, Robert P Giugliano, et al.Circulation|February 15, 2021
Comparison of the Efficacy and Safety Outcomes of Edoxaban in 8040 Women Versus 13 065 Men With Atrial Fibrillation in the ENGAGE AF-TIMI 48 TrialThomas A Zelniker, Maddalena Ardissino, Felicita Andreotti, et al.Journal of the American College of Cardiology|April 6, 2004
Association of a pulsatile blood flow pattern on coronary arteriography and short-term clinical outcomes in acute myocardial infarctionC Michael Gibson, Juhana Karha, Sabina A Murphy, et al.The New England Journal of Medicine|November 6, 2007
Prasugrel versus clopidogrel in patients with acute coronary syndromesStephen D Wiviott, Eugene Braunwald, Carolyn H McCabe, et al.Lancet (London, England)|March 15, 2015
Genetics and the clinical response to warfarin and edoxaban: findings from the randomised, double-blind ENGAGE AF-TIMI 48 trialJessica L Mega, Joseph R Walker, Christian T Ruff, et al.Journal of Clinical Pharmacology|June 24, 2009
Population pharmacokinetic analyses to evaluate the influence of intrinsic and extrinsic factors on exposure of prasugrel active metabolite in TRITON-TIMI 38Rebecca E Wrishko, C Steven Ernest, David S Small, et al.Pageof 69